Open | $6.940 |
Close | $6.290 |
Volume / Avg. | 2.519M / 1.467M |
Day Range | 6.190 - 7.000 |
52 Wk Range | 1.570 - 6.954 |
Market Cap | $470.427M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 2.84% |
Days to Cover | 2.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Annexon (NASDAQ: ANNX) through any online brokerage.
Other companies in Annexon’s space includes: Renovaro (NASDAQ:RENB), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR) and Celcuity (NASDAQ:CELC).
The latest price target for Annexon (NASDAQ: ANNX) was reported by Needham on Monday, March 4, 2024. The analyst firm set a price target for 16.00 expecting ANNX to rise to within 12 months (a possible 166.22% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Annexon (NASDAQ: ANNX) is $6.01 last updated March 18, 2024 at 7:40 PM EDT.
There are no upcoming dividends for Annexon.
Annexon’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Annexon.
Annexon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.